品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
罗恩 | R025811-10mg | 10mg | 现货 | 1020172-07-9 |
N-[3-叔丁基-1-(喹啉-6-基)-1H-吡唑-5-... N-[3-tert-Butyl-1-(quinolin-... |
98% |
|
|
罗恩 | R025811-50mg | 50mg | 现货 | 1020172-07-9 |
N-[3-叔丁基-1-(喹啉-6-基)-1H-吡唑-5-... N-[3-tert-Butyl-1-(quinolin-... |
98% |
|
|
罗恩 | R025811-1mg | 1mg | 现货 | 1020172-07-9 |
N-[3-叔丁基-1-(喹啉-6-基)-1H-吡唑-5-... N-[3-tert-Butyl-1-(quinolin-... |
98% |
|
|
阿拉丁 | D126373-10mg | 10mg | 现货 | 1020172-07-9 |
DCC-2036 (Rebastinib),抑制剂 DCC-2036 (Rebastinib) |
Moligand™, ≥98% |
|
|
阿拉丁 | D126373-50mg | 50mg | 现货 | 1020172-07-9 |
DCC-2036 (Rebastinib),抑制剂 DCC-2036 (Rebastinib) |
Moligand™, ≥98% |
|
|
阿拉丁 | R408600-1ml | 1ml | 现货 | 1020172-07-9 |
Rebastinib (DCC-2036) Rebastinib (DCC-2036) |
Moligand™, 10mM in DMSO |
|
|
阿拉丁 | D126373-5mg | 5mg | 现货 | 1020172-07-9 |
DCC-2036 (Rebastinib),抑制剂 DCC-2036 (Rebastinib) |
Moligand™, ≥98% |
|
|
毕得 | BD280341-10mg | 10mg | 现货 | 1020172-07-9 |
4-(4-(3-(3-(叔丁基)-1-(喹啉-6-基)-... 4-(4-(3-(3-(tert-Butyl)-1-(q... |
98% |
|
|
毕得 | BD280341-50mg | 50mg | 现货 | 1020172-07-9 |
4-(4-(3-(3-(叔丁基)-1-(喹啉-6-基)-... 4-(4-(3-(3-(tert-Butyl)-1-(q... |
98% |
|
|
毕得 | BD280341-100mg | 100mg | 现货 | 1020172-07-9 |
4-(4-(3-(3-(叔丁基)-1-(喹啉-6-基)-... 4-(4-(3-(3-(tert-Butyl)-1-(q... |
98% |
|
|
毕得 | BD280341-250mg | 250mg | 现货 | 1020172-07-9 |
4-(4-(3-(3-(叔丁基)-1-(喹啉-6-基)-... 4-(4-(3-(3-(tert-Butyl)-1-(q... |
98% |
|
|